Gregory S. Curhan

Insider Reports History

Entity
Individual
Location
600 California Street, 9 Th Floor, San Francisco, CA
Signature
/s/ Gregory S. Curhan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory S. Curhan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Serina Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 250K Aug 15, 2024 Direct
Angion Biomedica Corp. Chief Financial Officer Stock Option (Right to Buy) 100K Mar 2, 2022 Direct

Insider Reports Filed by Gregory S. Curhan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SER Serina Therapeutics, Inc. Aug 15, 2024 1 $0 4 Aug 20, 2024 Chief Financial Officer
SER Serina Therapeutics, Inc. Aug 15, 2024 0 $0 3 Aug 20, 2024 Chief Financial Officer
ELTX Angion Biomedica Corp. Mar 2, 2022 1 $0 4 Mar 4, 2022 Chief Financial Officer
ELTX Angion Biomedica Corp. Dec 15, 2021 1 $9.48K 4 Dec 16, 2021 Interim Chief Financial Officer